Braingrid Limited Announces Proposed Change of Business to an Investment Company and Proposed Name Change
TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”)…
TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) — Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”)…
CAMBRIDGE, Mass., Nov. 30, 2020 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
Information concerning the total number of voting rights and shares, provided pursuant to article L….
MacroGenics accesses EVERSANA’s full suite of commercial services for which both parties share expenses EVERSANA…
Disclosure of trading in own shares from November 23, 2020 to November 27, 2020 Attachment…
VANCOUVER, British Columbia and SEATTLE, Nov. 30, 2020 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ:…
MALVERN, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company…
BOSTON and JERUSALEM, Nov. 30, 2020 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader…
MALVERN, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical…
JERSEY, Channel Islands, Nov. 30, 2020 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics…